Hakan Kalay

3.2k total citations
60 papers, 2.4k citations indexed

About

Hakan Kalay is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Hakan Kalay has authored 60 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Immunology, 35 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Hakan Kalay's work include Immunotherapy and Immune Responses (43 papers), T-cell and B-cell Immunology (20 papers) and Glycosylation and Glycoproteins Research (15 papers). Hakan Kalay is often cited by papers focused on Immunotherapy and Immune Responses (43 papers), T-cell and B-cell Immunology (20 papers) and Glycosylation and Glycoproteins Research (15 papers). Hakan Kalay collaborates with scholars based in Netherlands, Germany and United States. Hakan Kalay's co-authors include Yvette van Kooyk, Juan J. García‐Vallejo, Martino Ambrosini, Wendy W. J. Unger, Kamran Nazmi, Jan G.M. Bolscher, Sven C. M. Bruijns, Cynthia M. Fehres, Joke M. M. den Haan and Sandra J. van Vliet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Hakan Kalay

59 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hakan Kalay Netherlands 31 1.5k 1.3k 258 198 185 60 2.4k
Wendy W. J. Unger Netherlands 34 2.0k 1.3× 919 0.7× 277 1.1× 183 0.9× 254 1.4× 68 3.3k
Peter M. Moyle Australia 28 705 0.5× 1.1k 0.8× 151 0.6× 174 0.9× 249 1.3× 66 2.1k
Florence Niedergang France 35 1.3k 0.9× 969 0.8× 195 0.8× 139 0.7× 155 0.8× 75 3.0k
Houping Ni United States 20 1.6k 1.1× 2.7k 2.1× 276 1.1× 138 0.7× 133 0.7× 39 4.4k
Paul F. McKay United Kingdom 30 1.4k 1.0× 1.4k 1.1× 176 0.7× 111 0.6× 160 0.9× 81 3.0k
Bram Slütter Netherlands 35 2.1k 1.4× 1.6k 1.2× 160 0.6× 162 0.8× 156 0.8× 81 3.7k
Melissa C. Hanson United States 15 911 0.6× 693 0.5× 222 0.9× 184 0.9× 52 0.3× 22 1.8k
Gregor S. D. Reid Canada 26 960 0.7× 707 0.5× 294 1.1× 50 0.3× 340 1.8× 71 2.1k
Bernhard B. Singer Germany 34 699 0.5× 972 0.8× 794 3.1× 755 3.8× 205 1.1× 92 2.9k
Robert Daniels United States 27 885 0.6× 1.3k 1.0× 203 0.8× 241 1.2× 99 0.5× 72 3.0k

Countries citing papers authored by Hakan Kalay

Since Specialization
Citations

This map shows the geographic impact of Hakan Kalay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakan Kalay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakan Kalay more than expected).

Fields of papers citing papers by Hakan Kalay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hakan Kalay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakan Kalay. The network helps show where Hakan Kalay may publish in the future.

Co-authorship network of co-authors of Hakan Kalay

This figure shows the co-authorship network connecting the top 25 collaborators of Hakan Kalay. A scholar is included among the top collaborators of Hakan Kalay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakan Kalay. Hakan Kalay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stolk, Dorian A., Sjoerd Schetters, Eelco D. Keuning, et al.. (2024). Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells. Pharmaceutics. 16(5). 581–581. 2 indexed citations
2.
Affandi, Alsya J., Bárbara Mesquita, Katarzyna Olesek, et al.. (2024). Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity. International Journal of Pharmaceutics. 660. 124254–124254. 7 indexed citations
3.
Kalay, Hakan, Serge A. Versteeg, Joyce Lübbers, et al.. (2023). Sialic acid–modified der p 2 allergen exerts immunomodulatory effects on human PBMCs. SHILAP Revista de lepidopterología. 3(1). 100193–100193. 1 indexed citations
4.
Olesek, Katarzyna, Joanna Grabowska, Alsya J. Affandi, et al.. (2022). Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses. Frontiers in Immunology. 13. 842241–842241. 14 indexed citations
5.
Stolk, Dorian A., Sophie K. Horrevorts, Sjoerd Schetters, et al.. (2021). Palmitoylated antigens for the induction of anti-tumor CD8+ T cells and enhanced tumor recognition. Molecular Therapy — Oncolytics. 21. 315–328. 9 indexed citations
6.
Affandi, Alsya J., Katarzyna Olesek, Joanna Grabowska, et al.. (2021). CD169 Defines Activated CD14+ Monocytes With Enhanced CD8+ T Cell Activation Capacity. Frontiers in Immunology. 12. 697840–697840. 40 indexed citations
7.
Grabowska, Joanna, Alsya J. Affandi, Chun Yin Jerry Lau, et al.. (2020). Optimization of Liposomes for Antigen Targeting to Splenic CD169+ Macrophages. Pharmaceutics. 12(12). 1138–1138. 19 indexed citations
8.
Stolk, Dorian A., Joyce Lübbers, Rieneke van de Ven, et al.. (2020). Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses. Frontiers in Immunology. 11. 990–990. 33 indexed citations
9.
Lübbers, Joyce, et al.. (2020). Activation of the C-Type Lectin MGL by Terminal GalNAc Ligands Reduces the Glycolytic Activity of Human Dendritic Cells. Frontiers in Immunology. 11. 305–305. 25 indexed citations
10.
Horrevorts, Sophie K., Karien Bloem, Pablo Secades, et al.. (2018). Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I. Frontiers in Immunology. 9. 1231–1231. 26 indexed citations
11.
Veninga, Henrike, Katarzyna Olesek, Joanna Grabowska, et al.. (2018). Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma. Frontiers in Immunology. 9. 1997–1997. 21 indexed citations
13.
Fehres, Cynthia M., Sven C. M. Bruijns, Hakan Kalay, et al.. (2015). Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells. Cellular and Molecular Immunology. 14(4). 360–370. 38 indexed citations
14.
Vliet, Sandra J. van, Ilona M. Vuist, Kristiaan Lenos, et al.. (2013). Human T Cell Activation Results in Extracellular Signal-regulated Kinase (ERK)-Calcineurin-dependent Exposure of Tn Antigen on the Cell Surface and Binding of the Macrophage Galactose-type Lectin (MGL)*. Journal of Biological Chemistry. 288(38). 27519–27532. 29 indexed citations
15.
Kooyk, Yvette van, Hakan Kalay, & Juan J. García‐Vallejo. (2013). Analytical Tools for the Study of Cellular Glycosylation in the Immune System. Frontiers in Immunology. 4. 451–451. 20 indexed citations
16.
García‐Vallejo, Juan J., Martino Ambrosini, Wilhelmina E. van Riel, et al.. (2012). Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Molecular Immunology. 53(4). 387–397. 89 indexed citations
17.
Joshi, Medha, Wendy W. J. Unger, Astrid J. van Beelen, et al.. (2011). DC-SIGN mediated antigen-targeting using glycan-modified liposomes: Formulation considerations. International Journal of Pharmaceutics. 416(2). 426–432. 29 indexed citations
18.
Singh, Satwinder, Manja Litjens, Hakan Kalay, et al.. (2011). Design of neo‐glycoconjugates that target the mannose receptor and enhance TLR‐independent cross‐presentation and Th1 polarization. European Journal of Immunology. 41(4). 916–925. 46 indexed citations
19.
Saeland, Eiríkur, Marein A.W.P. de Jong, Alexey A. Nabatov, et al.. (2009). MUC1 in human milk blocks transmission of human immunodeficiency virus from dendritic cells to T cells. Molecular Immunology. 46(11-12). 2309–2316. 78 indexed citations
20.
Hertog, Alice L. den, Jan van Marle, Enno C.I. Veerman, et al.. (2006). The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans. Biological Chemistry. 387(10/11). 1495–502. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026